ADAPY (Adaptimmune Therapeutics) Float Percentage Of Total Shares Outstanding: 82.56% (As of Aug. 26, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Adaptimmune Therapeutics Float Percentage Of Total Shares Outstanding?

Adaptimmune Therapeutics ADAPY +5.80% Float Percentage Of Total Shares Outstanding is 82.56% as of Aug. 26, 2026.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Adaptimmune Therapeutics's float shares is 218.82 Mil. Adaptimmune Therapeutics's total shares outstanding is 265.05 Mil. Adaptimmune Therapeutics's float percentage of total shares outstanding is 82.56%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Adaptimmune Therapeutics's Insider Ownership is 2.02%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Adaptimmune Therapeutics's Institutional Ownership is 0.63%.

Adaptimmune Therapeutics Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Adaptimmune Therapeutics's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=218.82/265.05
=82.56%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 82.56% mean?
Adaptimmune Therapeutics (ADAPY) has a Float Percentage Of Total Shares Outstanding of 82.56% as of Aug. 26, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Adaptimmune Therapeutics and its competitors.
Is Adaptimmune Therapeutics' Float Percentage Of Total Shares Outstanding too high?
Adaptimmune Therapeutics' current Float Percentage Of Total Shares Outstanding is 82.56%.
How does Adaptimmune Therapeutics' Float Percentage Of Total Shares Outstanding compare to BCLI and APRE?
Adaptimmune Therapeutics' Float Percentage Of Total Shares Outstanding of 82.56% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Biotechnology company?
A good Float Percentage Of Total Shares Outstanding depends on the Biotechnology industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Adaptimmune Therapeutics and its competitors. Adaptimmune Therapeutics's current Float Percentage Of Total Shares Outstanding is 82.56%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Adaptimmune Therapeutics stock overvalued right now?
Adaptimmune Therapeutics (ADAPY) has a current Float Percentage Of Total Shares Outstanding of 82.56%. The current Float Percentage Of Total Shares Outstanding is 82.56%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Adaptimmune Therapeutics (ADAPY), the current Float Percentage Of Total Shares Outstanding is 82.56% as of Aug. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Adaptimmune Therapeutics Business Description

Other Exchanges 473A:Germany
Address 99 Park Drive, Milton Park, The Innovation Centre, Abingdon, Oxfordshire, GBR, OX14 4RY
Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its product pipelines include ADP-600 [PRAME] and ADP-520 [CD70].